PlainPill

Zinc Lozenges

The short answer. There isn't much data on Zinc Lozenges yet — 7 mentions, 3 with a clear outcome — so treat these numbers as anecdotal. It is well studied — 11 meta-analyses on PubMed.

What users report
100%helped3 reports · few reports
3 helped0 mixed0 didn't help

From 7 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
11
meta-analyses
11
RCTs
56
papers

What Zinc Lozenges does, according to users

Of the people who reported each effect, the share who said it got better.

betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 11 meta-analyses on PubMed ↗ · 11 randomized trials ↗

Cochrane Database Syst Rev · 2013 · Meta-analysis / systematic review
Zinc for the common cold

Conclusion: Zinc administered within 24 hours of onset of symptoms reduces the duration of common cold symptoms in healthy people but some caution is needed due to the heterogeneity of the data. As the zinc lozenges formulation has been widely studied and there is a significant reduction in the duration of cold at a dose of ≥ 75 mg/day, for those considering using zinc it would be best to use it at this dose throughout the cold. Regarding prophylactic zinc supplementation, currently no firm recommendation can be made because of insufficient data. When using zinc lozenges (not as syrup or tablets) the like

PubMed 23775705 ↗
Cochrane Database Syst Rev · 2000 · Meta-analysis / systematic review
Zinc for the common cold

Conclusion: Evidence of the effects of zinc lozenges for treating the common cold is inconclusive. Given the potential for treatment to produce side effects, the use of zinc lozenges to treat cold symptoms deserves further study.

PubMed 10796643 ↗
Cochrane Database Syst Rev · 2011 · Meta-analysis / systematic review
Zinc for the common cold

Conclusion: Zinc administered within 24 hours of onset of symptoms reduces the duration and severity of the common cold in healthy people. When supplemented for at least five months, it reduces cold incidence, school absenteeism and prescription of antibiotics in children. There is potential for zinc lozenges to produce side effects. In view of this and the differences in study populations, dosages, formulations and duration of treatment, it is difficult to make firm recommendations about the dose, formulation and duration that should be used.

PubMed 21328251 ↗
Registered clinical trials

5 human trials on ClinicalTrials.gov test Zinc Lozenges — 3 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

50 mgas reported

Reported side effects

How often each side effect came up across all reports.

nausea ×1vomiting ×1nausea on ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

Other options for immunity

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate